Literature DB >> 30448960

Prevalence of osteoporosis with the World Health Organization diagnostic criteria in the Eastern Mediterranean Region: a systematic review and meta-analysis.

Mohammad Zamani1,2, Vahid Zamani3, Behzad Heidari4,5, Hadi Parsian6, Seyed Mokhtar Esmaeilnejad-Ganji7,8.   

Abstract

A systematic review and meta-analysis was conducted on the prevalence of osteoporosis in the Eastern Mediterranean Region. The overall pooled prevalence of osteoporosis was 24.4%. The prevalence has increased significantly over the recent years. The highest pooled prevalence was in Saudi Arabia (32.7%), and the lowest was in Kuwait (15.1%).
PURPOSE: To conduct a systematic review and meta-analysis on the prevalence of osteoporosis in the Eastern Mediterranean Region (EMR), as defined by the World Health Organization.
METHODS: We included all observational studies reporting the prevalence of osteoporosis among general population. We searched literatures from the databases of PubMed, Scopus, Web of Science, and Index Medicus for the EMR published between January 2000 and December 2017 with no restriction of language. Two reviewers independently contributed in study selection and data extraction. STATA software was used for analyzing the collected data.
RESULTS: A total of 1692 citations were retrieved. After excluding the irrelevant articles, 36 eligible studies were included. The overall pooled prevalence rate of osteoporosis in the EMR on 31,593 participants was 24.4% (95% confidence interval [CI], 20.4-28.4). Based on femoral densitometry, the prevalence of osteoporosis was 16.8% (95% CI, 9.5-24.2), and based on spinal densitometry, it was 24.3% (95% CI, 19.4-29.2). The pooled prevalence in males was 20.5% (95% CI, 10.5-30.5), compared with 24.4% (95% CI, 20.2-28.6) in females. The prevalence rate was significantly higher in 2007-2015 (32.7%; 95% CI, 25.1-40.3) than in 2000-2006 (19.8%; 95% CI, 12.5-27).
CONCLUSIONS: Our findings indicate a considerable prevalence of osteoporosis among the people of the EMR. The prevalence has increased during recent years, showing that osteoporosis is becoming a critical health problem in this region. Prevention and control measures need to be implemented by health service authorities.

Entities:  

Keywords:  Bone density; Osteoporosis; Prevalence; Systematic review

Mesh:

Year:  2018        PMID: 30448960     DOI: 10.1007/s11657-018-0540-7

Source DB:  PubMed          Journal:  Arch Osteoporos            Impact factor:   2.617


  10 in total

1.  Evaluation of Knowledge, Attitudes, and Practices Related to Osteoporosis and Correlates of Perceived High Risk among People Living in Two Main Districts of Lebanon.

Authors:  Joanna Nohra; Yonna Sacre; Afif Abdel-Nour; Haider Mannan
Journal:  J Osteoporos       Date:  2022-05-23

Review 2.  Global prevalence of osteoporosis among the world older adults: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Niloofar Darvishi; Yalda Bartina; Mojdeh Larti; Aliakbar Kiaei; Mahvan Hemmati; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Orthop Surg Res       Date:  2021-11-13       Impact factor: 2.359

3.  Aucubin slows the development of osteoporosis by inhibiting osteoclast differentiation via the nuclear factor erythroid 2-related factor 2-mediated antioxidation pathway.

Authors:  Yongfeng Zhang; Xin Liu; Yangyang Li; Minkai Song; Yutong Li; Anhui Yang; Yaqin Zhang; Di Wang; Min Hu
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

Review 4.  The global prevalence of osteoporosis in the world: a comprehensive systematic review and meta-analysis.

Authors:  Nader Salari; Hooman Ghasemi; Loghman Mohammadi; Mohammad Hasan Behzadi; Elham Rabieenia; Shamarina Shohaimi; Masoud Mohammadi
Journal:  J Orthop Surg Res       Date:  2021-10-17       Impact factor: 2.359

5.  Effects of urolithin A on osteoclast differentiation induced by receptor activator of nuclear factor-κB ligand via bone morphogenic protein 2.

Authors:  Zhe Wang; Guobin Qi; Zhuokai Li; Xu Cui; Shengyang Guo; Yueqi Zhang; Pan Cai; Xiuhui Wang
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

Review 6.  Pathophysiology of Demineralization, Part I: Attrition, Erosion, Abfraction, and Noncarious Cervical Lesions.

Authors:  W Eugene Roberts; Jonathan E Mangum; Paul M Schneider
Journal:  Curr Osteoporos Rep       Date:  2022-02-07       Impact factor: 5.096

7.  Synthesis and anti-osteoporosis activity of novel Teriparatide glycosylation derivatives.

Authors:  Nan Wang; Jingyang Li; Hui Song; Chao Liu; Honggang Hu; Hongli Liao; Wei Cong
Journal:  RSC Adv       Date:  2020-07-07       Impact factor: 4.036

8.  Associations of Bone Mineral Density with RANKL and Osteoprotegerin in Arab Postmenopausal Women: A Cross-Sectional Study.

Authors:  Osama E Amer; Kaiser Wani; Mohammed G A Ansari; Abdullah M Alnaami; Naji Aljohani; Saba Abdi; Syed D Hussain; Nasser M Al-Daghri; Majed S Alokail
Journal:  Medicina (Kaunas)       Date:  2022-07-22       Impact factor: 2.948

9.  Effects of Rambutan Peel (Nepheliumlappaceum) PhenolicExtract on RANKL-Induced Differentiation of RAW264.7 Cells into Osteoclasts and Retinoic Acid-Induced Osteoporosis in Rats.

Authors:  Yongliang Zhuang; Xiaodong Sun; Bingtong Liu; Hu Hou; Yun Sun
Journal:  Nutrients       Date:  2020-03-25       Impact factor: 5.717

10.  Bibliometric Analysis of Global Research Productivity on Vitamin D and Bone Metabolism (2001-2020): Learn from the Past to Plan Future.

Authors:  Ahmad Azam Malik; Mukhtiar Baig; Nadeem Shafique Butt; Muhammad Imran; Sami Hamdan Alzahrani; Zohair Jamil Gazzaz
Journal:  Nutrients       Date:  2022-01-27       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.